Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Covid-19 Vaccines

As India Approves 2 More Covid Vaccines, Indo-US Healthcare Collaboration Comes To Focus
As India Approves 2 More Covid Vaccines, Indo-US Healthcare Collaboration Comes To Focus PTIDec 29, 2021 02:17 PM +05:30 IST
Asian Development Bank Approves $1.5 Billion Loan To India For Procuring COVID-19 Vaccines
Asian Development Bank Approves $1.5 Billion Loan To India For Procuring COVID-19 VaccinesSwarajya StaffNov 25, 2021 02:58 PM +05:30 IST
Goa Completes Administration Of At Least One Dose Of COVID-19 Vaccine To Its Entire Eligible Population
Goa Completes Administration Of At Least One Dose Of COVID-19 Vaccine To Its Entire Eligible PopulationSwarajya StaffSep 11, 2021 08:44 AM +05:30 IST
Israel's Decision To Give Covid Booster Shots To All Vaccinated People Becomes Controversial
Israel's Decision To Give Covid Booster Shots To All Vaccinated People Becomes ControversialBhaswati Guha Majumder Aug 30, 2021 01:47 PM +05:30 IST
Karnataka To Administer Five Lakh COVID-19 Vaccine Doses A Day From September, Says CM Basavaraj Bommai
Karnataka To Administer Five Lakh COVID-19 Vaccine Doses A Day From September, Says CM Basavaraj BommaiSwarajya StaffAug 27, 2021 11:26 AM +05:30 IST
Reliance Life Sciences Gets Nod To Conduct Phase-1 Clinical Trials Of Its Two-Dose COVID-19 Vaccine
Reliance Life Sciences Gets Nod To Conduct Phase-1 Clinical Trials Of Its Two-Dose COVID-19 VaccineSwarajya StaffAug 27, 2021 09:48 AM +05:30 IST
Govt Responded To Private Sector Demands But Now It Is Failing To Pick Up 25 Per Cent Vaccine Quota: Piyush Goyal
Govt Responded To Private Sector Demands But Now It Is Failing To Pick Up 25 Per Cent Vaccine Quota: Piyush GoyalSwarajya StaffJul 26, 2021 11:31 AM +05:30 IST
India And Russia To Recognise Each Other's COVID-19 Vaccines To Further Ease Travel Between Two Countries
India And Russia To Recognise Each Other's COVID-19 Vaccines To Further Ease Travel Between Two CountriesSwarajya StaffJul 11, 2021 02:03 PM +05:30 IST
Ladakh Becomes First UT To Achieve 100 Per Cent First Dose Vaccine Coverage; Guest Population Jabbed Too
Ladakh Becomes First UT To Achieve 100 Per Cent First Dose Vaccine Coverage; Guest Population Jabbed TooSwarajya StaffJul 11, 2021 09:34 AM +05:30 IST
Phase-3 Trials Show Covaxin 93.4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing
Phase-3 Trials Show Covaxin 93.4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In ManufacturingSwarajya StaffJul 4, 2021 05:48 PM +05:30 IST
Bharat Biotech Submits Data From Covaxin's Phase-III Clinical Trial To DCGI: Report
Bharat Biotech Submits Data From Covaxin's Phase-III Clinical Trial To DCGI: ReportSwarajya StaffJun 22, 2021 09:11 AM +05:30 IST
Vaccine Supplies Continue To Surge,  13.5 Crore Doses To Be Available In July: Govt
Vaccine Supplies Continue To Surge, 13.5 Crore Doses To Be Available In July: GovtSwarajya StaffJun 20, 2021 09:41 AM +05:30 IST
US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its Efficacy
US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its EfficacySwarajya StaffJun 14, 2021 06:46 PM +05:30 IST
Bharat Biotech’s US-Based Partner Ocugen To Seek Emergency Use Nod From Health Canada For Covaxin
Bharat Biotech’s US-Based Partner Ocugen To Seek Emergency Use Nod From Health Canada For CovaxinSwarajya StaffJun 11, 2021 05:11 PM +05:30 IST
Centre To Administer 1 Crore Covid Vaccine Doses Per Day From August; 100 Crore Vaccine Order Planned
Centre To Administer 1 Crore Covid Vaccine Doses Per Day From August; 100 Crore Vaccine Order PlannedSwarajya StaffJun 10, 2021 10:08 AM +05:30 IST
Centre Will Look At Centralised Procurement Of COVID-19 Vaccines: Nirmala Sitharaman
Centre Will Look At Centralised Procurement Of COVID-19 Vaccines: Nirmala SitharamanSwarajya StaffJun 7, 2021 11:45 AM +05:30 IST
Haryana Govt Receives Bid From Malta-Based Company For Supply Of 60 Million Doses Of Sputnik V COVID-19 Vaccine
Haryana Govt Receives Bid From Malta-Based Company For Supply Of 60 Million Doses Of Sputnik V COVID-19 VaccineSwarajya StaffJun 6, 2021 10:38 AM +05:30 IST
Biological E's Upcoming COVID Vaccine Set To Be India's Most Affordable; To Be Priced Below Rs 400-500 For Both Doses
Biological E's Upcoming COVID Vaccine Set To Be India's Most Affordable; To Be Priced Below Rs 400-500 For Both DosesSwarajya StaffJun 5, 2021 11:12 AM +05:30 IST
Odisha Govt's Global Tender To Procure 3.8 Crore COVID-19 Vaccine Doses Receives Two Bids
Odisha Govt's Global Tender To Procure 3.8 Crore COVID-19 Vaccine Doses Receives Two BidsSwarajya StaffJun 5, 2021 10:01 AM +05:30 IST
Rajasthan: Covid Vaccine Vials Thrown Away, Burnt And Buried, Says Report; State Govt Denies Vaccine Wastage
Rajasthan: Covid Vaccine Vials Thrown Away, Burnt And Buried, Says Report; State Govt Denies Vaccine WastageSwarajya StaffJun 3, 2021 05:10 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype